Skip to main content
SpringerLink
Log in

Primum nil nocere

Primum nil nocere

  • Kommentare
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bhatnagar V, Kaplan RM (2005) Treatment options for prostate cancer: evaluating the evidence. Am Fam Physician 71(10):1915–1922

    PubMed  Google Scholar 

  2. Carlsson S. Aus G, Bergdahl S et al (2010) The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. the Göteborg randomised population-based prostate cancer screening trial. Eur J Cancer 47:545–553

    Article  PubMed  Google Scholar 

  3. Bergh R van den, Korfage IJ, Roobol MJ et al (2012) Sexual function with localized prostate cancer AS versus RT. BJU Int 110:1032–1039

    Article  PubMed  Google Scholar 

  4. AWMF (2014) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Langversion 3.1–2. Aktualisierung – Oktober 2014. AWMF-Register-Nummer 043/022OL. AWMF, Düsseldorf. http://leitlinienprogramm-onkologie.de

  5. Nam RK, Cheung P, Herschorn S et al (2014) Incidence of complications other than urinary incontinence or erectile dysfunktion after radical prostectomy or radiotherapy for prostate cancer: a population-based cohort study. Lancet Oncol 15:223–231

    Article  PubMed  Google Scholar 

  6. Parker C, Muston D, Melia J et al (2006) A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. Br J Cancer 94(10):1361–1368

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Dall’Era MA, Albertsen PC, Bangma C et al (2012) Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 62:976–983

    Article  Google Scholar 

  8. Thomsen BJ, Berg KD, Røder MA et al (2014) Active surveillance for clinically localized prostate cancer – a systematic review. J Surg Oncol 109:830–835

    Article  PubMed  Google Scholar 

  9. Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33(3):272–277

    Article  PubMed  Google Scholar 

  10. Wiegel TH, Stöckle M, Bartkowiak D (2015) PREFEREnce-based randomized evaluation of treatment modalities in low or early intermediate-risk prostate cancer. Eur Urol 67:1–2

    Article  PubMed  Google Scholar 

  11. Lane JA, Donovan JL, Davis M et al (2014) Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol 15:1109–1118

    Article  PubMed  Google Scholar 

  12. U.S. National Institutes of Health (2013) START: ClinicalTrials.gov. Identifier NCT 00499174

    Google Scholar 

  13. Wallis CJ, Herschorn S, Saskin R et al (2015) Complications after radical prostatectomy or radiotherapy for prostate cancer: results of a population-based, propensity score-matched analysis. Urology 85(3):621–628

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. C. Roloff gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Fachärztin für Allgemeinmedizin, Münchnerstraße 25, 82041, Oberhaching, Deutschland

    C. Roloff

Authors
  1. C. Roloff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Roloff.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roloff, C. Primum nil nocere. Urologe 54, 1433–1434 (2015). https://doi.org/10.1007/s00120-015-3939-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-015-3939-4

Search

Navigation